Patients at risk of onychomycosis--risk factor identification and active prevention.
about
Risk Factors and Comorbidities for Onychomycosis: Implications for Treatment with Topical TherapyOnychomycosis: Practical Approaches to Minimize Relapse and RecurrencePsychosocial perception of adults with onychomycosis: a blinded, controlled comparison of 1,017 adult Hong Kong residents with or without onychomycosisDo fungi play a role in psoriatic nails?Onychomycosis in patients with chronic leg ulcer and toenail abnormalities.Tazarotene as alternative topical treatment for onychomycosis.Descriptive study of onychomycosis in a hospital in São PauloNovel investigational therapies for onychomycosis: an update.A randomised comparative study of 1064 nm Neodymium-doped yttrium aluminium garnet (Nd:YAG) laser and topical antifungal treatment of onychomycosis.Therapeutic potential of TDT 067 (terbinafine in Transfersome): a carrier-based dosage form of terbinafine for onychomycosis.Tavaborole (AN-2690) for the treatment of onychomycosis of the toenail in adults.Onychomycosis nailed.Toenail Onychomycosis-A Canadian Approach With a New Transungual Treatment: Development of a Clinical Pathway.Prevalence, Etiology, and Risk Factors of Tinea Pedis and Tinea Unguium in TunisiaImproving Cure Rates in Onychomycosis.Causative Agents of Onychomycosis: A 7-Year Study.The prevalence of Candida onychomycosis in Southeastern Serbia from 2011 to 2015.Epidemiology of onychomycosis in Crete, Greece: a 12-year study.Prevalence of Candida tropicalis and Candida krusei in onychomycosis in João Pessoa, Paraiba, Brazil from 1999 to 2010.Epidemiological study of onychomycosis in older adults with onychodystrophy.Establishment of a novel model of onychomycosis in rabbits for evaluation of antifungal agents.Evaluation of the morphological effects of TDT 067 (terbinafine in Transfersome) and conventional terbinafine on dermatophyte hyphae in vitro and in vivo.Activity of TDT 067 (terbinafine in Transfersome) against agents of onychomycosis, as determined by minimum inhibitory and fungicidal concentrationsSanitization of contaminated footwear from onychomycosis patients using ozone gas: a novel adjunct therapy for treating onychomycosis and tinea pedis?Onychomycosis and OnychomatricomaTreatment strategies for alopeciaToenail Onychomycosis in a Portuguese Geriatric PopulationThe Impact of Onychomycosis on Quality of Life: A Systematic Review of the Available Literature
P2860
Q26771955-9A5FD19F-6AC0-441A-9329-643E1B940944Q28073085-59CC1E6C-3E45-43E4-8032-F3F0C4BD438DQ33936313-D8BBFF7B-8836-4AC2-8F1C-D726CCD97087Q34703147-7EBED335-6BA1-47C6-BC9F-226BFDFEB561Q35070382-03B14D96-5B84-4354-AC4C-1F3BC834A18CQ35113266-79A13782-9234-4AE0-B890-658B334E1065Q35866516-9D59B08A-40E3-4628-AB4D-3080DCCC84A2Q35893705-C52E23EE-A7F7-43E3-9B3B-8D86B3F1B27AQ36073484-49766DEA-7446-4286-838F-7919B7A06F77Q38033192-14DF9A52-9A44-4AE1-AD3A-43C5BFC40772Q38217420-B70810C7-1BBA-407B-9075-4B3EDF14EEA6Q38326477-BBA62018-8A61-4D73-80B5-ECE92A0C1EECQ38413107-07FC164E-0422-4BBE-9212-2146DA345460Q38602870-1C9D44BF-2754-441C-A766-8DBA0FBA1306Q38867934-0A500630-2F02-43BF-87AB-6640252027AEQ39240161-351E8EFF-AC5F-412D-8403-D6369082D66FQ40164935-9F4F90DD-B70F-44FB-8569-9A8502E3BED2Q40608450-647BA1EC-A3D2-49DA-ACF8-3466A73C9F72Q40997362-6F3D9FEA-6DDB-461F-8952-3C4E9575F9A5Q41225586-36BB565D-C837-4B3D-8275-94FB08155747Q41833384-B505D273-4FC7-47A0-9163-902EDDD361A3Q42110698-1E4F9AD5-D1E2-45B8-B52A-6316E65CD5FAQ42150481-D9D7E107-81C0-4D0C-BBF0-8B0B6B375B72Q42286876-83A4FE07-7BC3-4341-9931-5917C0EA6807Q42712052-7787B350-E31C-4FD6-B11D-A7EA7CBAAC61Q56991024-968FE96D-8FBF-456F-9DF7-A030C06B5F54Q58077688-BF224A9F-09F1-4CD5-BA15-FAFE595888BEQ58602774-1937878A-41BD-4958-A2CB-B92CAAD209EC
P2860
Patients at risk of onychomycosis--risk factor identification and active prevention.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Patients at risk of onychomycosis--risk factor identification and active prevention.
@ast
Patients at risk of onychomycosis--risk factor identification and active prevention.
@en
type
label
Patients at risk of onychomycosis--risk factor identification and active prevention.
@ast
Patients at risk of onychomycosis--risk factor identification and active prevention.
@en
prefLabel
Patients at risk of onychomycosis--risk factor identification and active prevention.
@ast
Patients at risk of onychomycosis--risk factor identification and active prevention.
@en
P2860
P1476
Patients at risk of onychomycosis--risk factor identification and active prevention
@en
P2093
R Arenas-Guzmán
P2860
P356
10.1111/J.1468-3083.2005.01282.X
P478
19 Suppl 1
P577
2005-09-01T00:00:00Z